Reaction

Sensation Of Heaviness reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,882 reports · 41 co-occurring drugs

As of the last recalculation, Sensation Of Heaviness appears in 3,882 FAERS reports alongside 41 co-occurring drug terms. The strongest observed disproportionality signal is NATALIZUMAB (PRR 17.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Natalizumab	527	17.8	17.9
Interferon Beta-1A	505	16.0	16.0
Interferon Beta-1B	41	11.6	11.6
Raloxifene Hydrochloride	19	7.0	7.0
Valsartan And Hydrochlorothiazide	17	6.7	6.7
Lisinopril And Hydrochlorothiazide Tablets	9	6.2	6.2
Loratadine And Pseudoephedrine Sulfate	9	6.1	6.1
Rizatriptan Benzoate	11	5.8	5.8
Ezetimibe And Simvastatin	16	5.7	5.7
Lisinopril And Hydrochlorothiazide	10	5.3	5.3
Amlodipine Besylate And Valsartan	10	4.9	4.9
Drospirenone And Ethinyl Estradiol	37	4.5	4.5
Desloratadine	9	4.5	4.5
Sulfur	7	4.5	4.5
Sumatriptan	31	4.4	4.4
Dalfampridine	54	4.1	4.1
Amlodipine Besylate And Benazepril Hydrochloride	7	4.1	4.1
Metformin Hcl	40	3.9	3.9
Exenatide	37	3.8	3.8
Ibuprofen And Diphenhydramine Citrate	16	3.7	3.7
Teriparatide	73	3.5	3.5
Desvenlafaxine Succinate	17	3.4	3.4
Varenicline Tartrate	50	3.4	3.4
Atorvastatin Calcium	151	3.4	3.4
Modafinil	19	3.2	3.2
Ziprasidone Mesylate	8	3.0	3.0
Fingolimod Hcl	48	3.0	3.0
Multivitamin	27	2.9	2.9
Onabotulinumtoxina	40	2.8	2.8
Dimethyl Fumarate	63	2.8	2.8
Asenapine Maleate	4	2.5	2.5
Nicotine	17	2.3	2.3
Atomoxetine Hydrochloride	10	2.3	2.3
Peginterferon Alfa-2A	22	2.2	2.2
Lapatinib	6	2.1	2.1
Paricalcitol	5	1.9	1.9
Ribavirin	21	1.8	1.8
Botulinum Toxin Type A	4	1.7	1.7
Glatiramer Acetate	19	1.7	1.7
Orlistat	8	1.7	1.7
Levonorgestrel	23	0.6	0.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.